Magellen Gets Warning Letter On Lead Test Concerns
Executive Summary
The warning letter alleges the company sold modified versions of its blood lead tests without alerting US FDA, and didn’t tell the agency about reported discrepancies in test results. FDA first warned of possible faulty test results in May.